Figure 1: 18F-labeled fluoro-2-deoxyglucose PET/CT; Maximum intensity projection image (a) of positron-emission tomography shows focal increased fluoro-2-deoxyglucose uptake in the left hemithorax and multiple areas of increased tracer uptake in the liver. PET/CT fused (trans-axial [b and c] and coronal [d]) and CT-images (transaxial [e and f] and coronal [g]) revealed intense fluoro-2-deoxyglucose uptake in pleural-based nodule in the left lung lower lobe ([b]: arrow) and intensely fluoro-2-deoxyglucose-avid multiple hypodense lesions in enlarged liver ([c]: dashed arrow). Note was also made of mild heterogeneous tracer uptake in the marrow ([a]: black arrow) and enlarged spleen with no abnormal fluoro-2-deoxyglucose uptake ([d]: arrowhead)
![Figure 1: 18F-labeled fluoro-2-deoxyglucose PET/CT; Maximum intensity projection image (a) of positron-emission tomography shows focal increased fluoro-2-deoxyglucose uptake in the left hemithorax and multiple areas of increased tracer uptake in the liver. PET/CT fused (trans-axial [b and c] and coronal [d]) and CT-images (transaxial [e and f] and coronal [g]) revealed intense fluoro-2-deoxyglucose uptake in pleural-based nodule in the left lung lower lobe ([b]: arrow) and intensely fluoro-2-deoxyglucose-avid multiple hypodense lesions in enlarged liver ([c]: dashed arrow). Note was also made of mild heterogeneous tracer uptake in the marrow ([a]: black arrow) and enlarged spleen with no abnormal fluoro-2-deoxyglucose uptake ([d]: arrowhead)](articles/2020/35/1/images/IndianJNuclMed_2020_35_1_70_274370_f1.jpg)